Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial
Importance Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19)
is limited. Objective To determine whether hydrocortisone improves outcome for …
is limited. Objective To determine whether hydrocortisone improves outcome for …
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. Rationale and design
…, Y Arabi, W van Bentum-Puijk, Z Bhimani… - Annals of the …, 2020 - atsjournals.org
There is broad interest in improved methods to generate robust evidence regarding best
practice, especially in settings where patient conditions are heterogenous and require multiple …
practice, especially in settings where patient conditions are heterogenous and require multiple …
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Purpose To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill
patients with coronavirus disease 2019 (COVID-19). Methods Critically ill adults with COVID-19 …
patients with coronavirus disease 2019 (COVID-19). Methods Critically ill adults with COVID-19 …
Effectiveness of tocilizumab, sarilumab, and anakinra for critically ill patients with COVID-19 the REMAP-CAP COVID-19 immune modulation therapy domain …
BACKGROUND The interleukin-6 receptor antagonist tocilizumab improves outcomes in
critically ill patients with coronavirus disease 2019 (COVID-19). However, the effectiveness of …
critically ill patients with coronavirus disease 2019 (COVID-19). However, the effectiveness of …
Heterogeneous treatment effects of therapeutic-dose heparin in patients hospitalized for COVID-19
…, A Beane, JS Berger, SM Berry, Z Bhimani… - Jama, 2023 - jamanetwork.com
Importance Randomized clinical trials (RCTs) of therapeutic-dose heparin in patients hospitalized
with COVID-19 produced conflicting results, possibly due to heterogeneity of treatment …
with COVID-19 produced conflicting results, possibly due to heterogeneity of treatment …
[HTML][HTML] Effect of antiplatelet therapy on survival and organ support–free days in critically ill patients with COVID-19: a randomized clinical trial
Interventions Patients were randomized to receive either open-label aspirin (n= 565), a
P2Y12 inhibitor (n= 455), or no antiplatelet therapy (control; n= 529). Interventions were …
P2Y12 inhibitor (n= 455), or no antiplatelet therapy (control; n= 529). Interventions were …
Co-designing and pilot testing an infographic to support patients/families through the REMAP-CAP consent process: a mixed-methods study protocol
HK O'Grady, Z Bhimani, S Dalziel, B Dolanjski… - Pilot and Feasibility …, 2023 - Springer
Background Informed consent is critical to the ethical conduct of clinical research and requires
understanding of a trial including its purpose, process, potential risks and benefits, and …
understanding of a trial including its purpose, process, potential risks and benefits, and …
Three decades of collaboration in critical care research
KEA Burns, SD Yan, K Thorpe, Z Bhimani… - American Journal of …, 2020 - atsjournals.org
Three Decades of Collaboration in Critical Care Research the males, exceeding the minimum
clinically important difference (MCID) of 3 (7) and indicating persistently worse global …
clinically important difference (MCID) of 3 (7) and indicating persistently worse global …
